Who Owns ArriVent BioPharma Stock?
NASDAQ: AVBPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 98.79%
- Institutions (% of float)
- 100.34%
- Held by insiders
- 1.54%
- Institutional holders
- 217
- Institutions 98.5%
- Insiders 1.5%
- Public and other 0.0%
Who owns ArriVent BioPharma stock?
Institutional investors own about 98.8% of ArriVent BioPharma's shares, spread across 217 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 1.54% of AVBP.
The largest institutional holders are Montanova Capital LLC (9.16%), Infinitum Asset Management, LLC (9.00%) and HHLR Advisors, LTD (7.97%). Together, the top 10 institutions control 59.0% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their AVBP positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of AVBP
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Montanova Capital LLC | 4.52M | 9.16% | +2.6% |
| Infinitum Asset Management, LLC | 4.44M | 9.00% | +7.0% |
| HHLR Advisors, LTD | 3.93M | 7.97% | 0.0% |
| Blackrock Inc. | 3.25M | 6.59% | +28.5% |
| Orbimed Advisors LLC. | 3.03M | 6.14% | 0.0% |
| FMR, LLC | 2.78M | 5.64% | -7.9% |
| Octagon Capital Advisors LP | 1.97M | 4.00% | 0.0% |
| Vanguard Capital Management LLC | 1.77M | 3.60% | +16.1% |
| Sofinnova Investments, Inc. | 1.70M | 3.44% | 0.0% |
| State Street Corporation | 1.69M | 3.43% | +19.1% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of AVBP
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.34M | 2.72% |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 1.32M | 2.68% |
| iShares Trust-iShares Russell 2000 ETF | 970.01K | 1.97% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 925.97K | 1.88% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 414.87K | 0.84% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 397.08K | 0.81% |
| iShares Trust-iShares Russell 2000 Growth ETF | 352.69K | 0.72% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 323.64K | 0.66% |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 298.74K | 0.61% |
| iShares Trust-iShares Biotechnology ETF | 242.92K | 0.49% |
Frequently asked questions
Who is the largest shareholder of ArriVent BioPharma?
Montanova Capital LLC is the largest institutional shareholder of AVBP, owning 9.16% of shares outstanding (4.52M shares) as of its latest 13F filing.
What percentage of ArriVent BioPharma is owned by institutions?
Institutions own about 98.8% of AVBP shares and 100.3% of the public float.
How much of ArriVent BioPharma do insiders own?
Insiders, such as officers and directors, own about 1.54% of AVBP shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.